An analysis of variance type method to describe and compare steady states in clinical data

Research output: Chapter in book/report/conference proceedingConference contributionResearchpeer review

Authors

  • Dammon Ziaian
  • Stefan Zimmermann
  • Lutz Duembgen
  • Astrid E. Berggreen
  • Martin Grossherr
  • Hartmut Gehring
  • Andreas Hengstenberg

External Research Organisations

  • University of Bern
  • University Medical Center Schleswig-Holstein (UKSH)
  • Drägerwerk AG & co. KG
View graph of relations

Details

Original languageEnglish
Title of host publication2013 E-Health and Bioengineering Conference (EHB)
Number of pages4
ISBN (electronic)9781479923731, 9781479923724
Publication statusPublished - 9 Jan 2014
Event4th IEEE International Conference on e-Health and Bioengineering - Iasi, Romania
Duration: 21 Nov 201323 Nov 2013
Conference number: 4
https://www.ehealthnews.eu/events/3670-ieee-international-conference-on-e-health-and-bioengineering-ehb-2013

Abstract

Identifying and comparing different steady states is an important task for clinical decision making. Data from unequal sources, comprising diverse patient status information, have to be interpreted. In order to compare results an expressive representation is the key. In this contribution we suggest a criterion to calculate a context-sensitive value based on variance analysis and discuss its advantages and limitations referring to a clinical data example obtained during anesthesia. Different drug plasma target levels of the anesthetic propofol were preset to reach and maintain clinically desirable steady state conditions with target controlled infusion (TCI). At the same time systolic blood pressure was monitored, depth of anesthesia was recorded using the bispectral index (BIS) and propofol plasma concentrations were determined in venous blood samples. The presented analysis of variance (ANOVA) is used to quantify how accurately steady states can be monitored and compared using the three methods of measurement.

Keywords

    ANOVA, BIS, propofol, steady state, TCI

ASJC Scopus subject areas

Cite this

An analysis of variance type method to describe and compare steady states in clinical data. / Ziaian, Dammon; Zimmermann, Stefan; Duembgen, Lutz et al.
2013 E-Health and Bioengineering Conference (EHB). 2014.

Research output: Chapter in book/report/conference proceedingConference contributionResearchpeer review

Ziaian, D, Zimmermann, S, Duembgen, L, Berggreen, AE, Grossherr, M, Gehring, H & Hengstenberg, A 2014, An analysis of variance type method to describe and compare steady states in clinical data. in 2013 E-Health and Bioengineering Conference (EHB). 4th IEEE International Conference on e-Health and Bioengineering, Iasi, Romania, 21 Nov 2013. https://doi.org/10.1109/EHB.2013.6707416
Ziaian, D., Zimmermann, S., Duembgen, L., Berggreen, A. E., Grossherr, M., Gehring, H., & Hengstenberg, A. (2014). An analysis of variance type method to describe and compare steady states in clinical data. In 2013 E-Health and Bioengineering Conference (EHB) https://doi.org/10.1109/EHB.2013.6707416
Ziaian D, Zimmermann S, Duembgen L, Berggreen AE, Grossherr M, Gehring H et al. An analysis of variance type method to describe and compare steady states in clinical data. In 2013 E-Health and Bioengineering Conference (EHB). 2014 doi: 10.1109/EHB.2013.6707416
Ziaian, Dammon ; Zimmermann, Stefan ; Duembgen, Lutz et al. / An analysis of variance type method to describe and compare steady states in clinical data. 2013 E-Health and Bioengineering Conference (EHB). 2014.
Download
@inproceedings{26326d62d4074b4f98ffce917e383d8f,
title = "An analysis of variance type method to describe and compare steady states in clinical data",
abstract = "Identifying and comparing different steady states is an important task for clinical decision making. Data from unequal sources, comprising diverse patient status information, have to be interpreted. In order to compare results an expressive representation is the key. In this contribution we suggest a criterion to calculate a context-sensitive value based on variance analysis and discuss its advantages and limitations referring to a clinical data example obtained during anesthesia. Different drug plasma target levels of the anesthetic propofol were preset to reach and maintain clinically desirable steady state conditions with target controlled infusion (TCI). At the same time systolic blood pressure was monitored, depth of anesthesia was recorded using the bispectral index (BIS) and propofol plasma concentrations were determined in venous blood samples. The presented analysis of variance (ANOVA) is used to quantify how accurately steady states can be monitored and compared using the three methods of measurement.",
keywords = "ANOVA, BIS, propofol, steady state, TCI",
author = "Dammon Ziaian and Stefan Zimmermann and Lutz Duembgen and Berggreen, {Astrid E.} and Martin Grossherr and Hartmut Gehring and Andreas Hengstenberg",
year = "2014",
month = jan,
day = "9",
doi = "10.1109/EHB.2013.6707416",
language = "English",
booktitle = "2013 E-Health and Bioengineering Conference (EHB)",
note = "4th IEEE International Conference on e-Health and Bioengineering, EHB 2013 ; Conference date: 21-11-2013 Through 23-11-2013",
url = "https://www.ehealthnews.eu/events/3670-ieee-international-conference-on-e-health-and-bioengineering-ehb-2013",

}

Download

TY - GEN

T1 - An analysis of variance type method to describe and compare steady states in clinical data

AU - Ziaian, Dammon

AU - Zimmermann, Stefan

AU - Duembgen, Lutz

AU - Berggreen, Astrid E.

AU - Grossherr, Martin

AU - Gehring, Hartmut

AU - Hengstenberg, Andreas

N1 - Conference code: 4

PY - 2014/1/9

Y1 - 2014/1/9

N2 - Identifying and comparing different steady states is an important task for clinical decision making. Data from unequal sources, comprising diverse patient status information, have to be interpreted. In order to compare results an expressive representation is the key. In this contribution we suggest a criterion to calculate a context-sensitive value based on variance analysis and discuss its advantages and limitations referring to a clinical data example obtained during anesthesia. Different drug plasma target levels of the anesthetic propofol were preset to reach and maintain clinically desirable steady state conditions with target controlled infusion (TCI). At the same time systolic blood pressure was monitored, depth of anesthesia was recorded using the bispectral index (BIS) and propofol plasma concentrations were determined in venous blood samples. The presented analysis of variance (ANOVA) is used to quantify how accurately steady states can be monitored and compared using the three methods of measurement.

AB - Identifying and comparing different steady states is an important task for clinical decision making. Data from unequal sources, comprising diverse patient status information, have to be interpreted. In order to compare results an expressive representation is the key. In this contribution we suggest a criterion to calculate a context-sensitive value based on variance analysis and discuss its advantages and limitations referring to a clinical data example obtained during anesthesia. Different drug plasma target levels of the anesthetic propofol were preset to reach and maintain clinically desirable steady state conditions with target controlled infusion (TCI). At the same time systolic blood pressure was monitored, depth of anesthesia was recorded using the bispectral index (BIS) and propofol plasma concentrations were determined in venous blood samples. The presented analysis of variance (ANOVA) is used to quantify how accurately steady states can be monitored and compared using the three methods of measurement.

KW - ANOVA

KW - BIS

KW - propofol

KW - steady state

KW - TCI

UR - http://www.scopus.com/inward/record.url?scp=84893762701&partnerID=8YFLogxK

U2 - 10.1109/EHB.2013.6707416

DO - 10.1109/EHB.2013.6707416

M3 - Conference contribution

AN - SCOPUS:84893762701

BT - 2013 E-Health and Bioengineering Conference (EHB)

T2 - 4th IEEE International Conference on e-Health and Bioengineering

Y2 - 21 November 2013 through 23 November 2013

ER -

By the same author(s)